• Home
  • Research
    • Neuroblastoma Research >
      • Chromosomal copy number alterations as smoking guns for new therapeutic targets in neuroblastoma
      • Novel combination therapies targeting replication stress resistance and DNA damage repair
      • Targeted protein degradation - PROTAC development
      • ingle-cell and spatial multi-omics mapping of immunomodulatory drug responses
    • PEDIATRIC SARCOMA RESEARCH
    • Patient Avatar Models
  • Publications
  • News
  • People
  • Donate
  • Contact
  • Home
  • Research
    • Neuroblastoma Research >
      • Chromosomal copy number alterations as smoking guns for new therapeutic targets in neuroblastoma
      • Novel combination therapies targeting replication stress resistance and DNA damage repair
      • Targeted protein degradation - PROTAC development
      • ingle-cell and spatial multi-omics mapping of immunomodulatory drug responses
    • PEDIATRIC SARCOMA RESEARCH
    • Patient Avatar Models
  • Publications
  • News
  • People
  • Donate
  • Contact

Development of PROTACS for targeted protein degradation

Aurora kinase A (AURKA) is a well-established target in neuroblastoma (NB) due to both its catalytic functions during mitosis and its kinase-independent functions, including stabilization of the key oncoprotein MYCN.
Picture

Pediatric Precision Oncology Lab Ghent

Understanding childhood cancer
​development for better cures


Donate

Medical Research Building (MRB), 2nd floor
Corneel Heymanslaan 10, B-9000 Ghent, Belgium
​

Tel: +32 9 332 55 33
Email: [email protected]
PPOL lab © 2024
  • Home
  • Research
    • Neuroblastoma Research >
      • Chromosomal copy number alterations as smoking guns for new therapeutic targets in neuroblastoma
      • Novel combination therapies targeting replication stress resistance and DNA damage repair
      • Targeted protein degradation - PROTAC development
      • ingle-cell and spatial multi-omics mapping of immunomodulatory drug responses
    • PEDIATRIC SARCOMA RESEARCH
    • Patient Avatar Models
  • Publications
  • News
  • People
  • Donate
  • Contact